Hepatic Angiosarcoma Presenting as an Acute Intraabdominal Hemorrhage Treated with Transarterial Chemoembolization

Stambo, Glenn William; Guiney, Michael J.

doi:https://doi.org/10.1155/2007/90169

Sarcoma

On this page

Abstract References Copyright Related Articles

Case Report | Open Access

Volume 2007 | Article ID 090169 | https://doi.org/10.1155/2007/90169

Hepatic Angiosarcoma Presenting as an Acute Intraabdominal Hemorrhage Treated with Transarterial Chemoembolization

Glenn William Stambo¹and Michael J. Guiney²

Academic Editor: Alessandro Gronchi

Received09 Mar 2007

Accepted25 Oct 2007

Published03 Dec 2007

Abstract

Primary malignant neoplasms of the liver are some of the most uncommon malignancies in many parts of the world. They include hepatocellular carcinoma and stromal tumors such as hepatic angiosarcoma. It is a lethal tumor with life expectancy of less than six months. Once discovered, it is often too late for surgical intervention. Like other vascular tumors of the liver and spleen, intraperitoneal hemorrhage is a well-documented finding of angiosarcoma which can be lethal if not diagnosed and treated immediately. As in our case, intraperitoneal hemorrhage from primary tumor rupture was the only clinical presentation of this neoplasm. Approximately 15% of patients present with acute hemoperitoneum from either tumor rupture or peritoneal metastasis. Although several therapeutic options are available, we describe apalliative therapy for hepatic angiosarcoma utilizing transcatheter arterial chemoembolization (TACE) techniques incorporating the newer embolization agent Embospheres to locally target and treat this aggressive tumor.

References

H. Mani and D. H. Van Thiel, “Mesenchymal tumors of the liver,” Clinics in Liver Disease, vol. 5, no. 1, pp. 219–257, 2001.
View at: Publisher Site | Google Scholar
E. Molina and A. Hernandez, “Clinical manifestations of primary hepatic angiosarcoma,” Digestive Diseases and Sciences, vol. 48, no. 4, pp. 677–682, 2003.
View at: Publisher Site | Google Scholar
C. H. Timaran, O. H. Grandas, and J. L. Bell, “Hepatic angiosarcoma: long-term survival after complete surgical removal,” American Surgeon, vol. 66, no. 12, pp. 1153–1157, 2000.
View at: Google Scholar
G. T. Budd, “Management of angiosarcoma,” Current Oncology Reports, vol. 4, no. 6, pp. 515–519, 2002.
View at: Publisher Site | Google Scholar
T. Koyama, J. G. Fletcher, C. D. Johnson, M. S. Kuo, K. Notohara, and L. J. Burgart, “Primary hepatic angiosarcoma: findings at CT and MR imaging,” Radiology, vol. 222, no. 3, pp. 667–673, 2002.
View at: Publisher Site | Google Scholar
J.-F. H. Geschwind, “Chemoembolization for hepatocellular carcinoma: where does the truth lie?” Journal of Vascular and Interventional Radiology, vol. 13, no. 10, pp. 991–994, 2002.
View at: Publisher Site | Google Scholar
I. Özden, O. Bilge, M. Erkan, U. Cevikbaş, and K. Acarli, “Five years and 4 months of recurrence-free survival in hepatic angiosarcoma,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 10, no. 3, pp. 250–252, 2003.
View at: Publisher Site | Google Scholar
E. B. Sussman, I. Nydick, and G. F. Gray, “Hemangioendothelial sarcoma of the liver and hemochromatosis,” Archives of Pathology, vol. 97, no. 1, pp. 39–42, 1974.
View at: Google Scholar
C. D. Blanke, B. L. Eisenberg, and M. C. Heinrich, “Gastrointestinal stromal tumors,” Current Treatment Options in Oncology, vol. 2, no. 6, pp. 485–491, 2001.
View at: Publisher Site | Google Scholar
P. G. Tarazov, V. K. Ryzhkov, A. B. Markochev, and A. A. Noskov, “Palliative treatment of angiosarcoma of the liver using roentgeno-endovascular occlusion of the hepatic artery,” Voprosy Onkologii, vol. 34, no. 6, pp. 744–746, 1988 (Russian).
View at: Google Scholar
R. Tordjman, C. Eugene, O. Clouet, L. Wesenfelder, C. Collet, and A. Bergue, “Hepatosplenic angiosarcoma complicated by hemoperitoneum and disseminated intravascular coagulation. Treatment by arterial embolization and chemotherapy,” Gastroenterologie Clinique et Bilogique, vol. 19, no. 6-7, pp. 625–628, 1995 (French).
View at: Google Scholar
E. Liapi and J.-F. H. Geschwind, “Transcatheter arterial chemoembolisation (TACE) for HCC-classic concepts and future evolution,” European Oncological Disease, pp. 47–52, 2006.
View at: Google Scholar
R. Salem, R. Lewandowski, C. Roberts et al., “Use of Yttrium-90 glass microspheres (therasphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis,” Journal of Vascular and Interventional Radiology, vol. 15, no. 4, pp. 335–345, 2004.
View at: Google Scholar
D. A. Iannitti, D. E. Dupuy, W. W. Mayo-Smith, and B. Murphy, “Hepatic radiofrequency ablation,” Archives of Surgery, vol. 137, no. 4, pp. 422–427, 2002.
View at: Publisher Site | Google Scholar
K.-H. Lee, K.-B. Sung, D.-Y. Lee, S. J. Park, K. W. Kim, and J.-S. Yu, “Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein,” Radiographics, vol. 22, no. 5, pp. 1077–1091, 2002.
View at: Google Scholar

Copyright

Copyright © 2007 Glenn William Stambo and Michael J. Guiney. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation Order printed copies

Views

420

Downloads

1052

Citations